Global Leaders Driving The Future Of Healthcare At The 2025 Forbes Healthcare Summit [Forbes]
Vir Biotechnology, Inc. (VIR)
Company Research
Source: Forbes
New York, NY – November 18, 2025 – Forbes is set to host its 14th Annual Healthcare Summit on Thursday, December 4, in New York City and virtually. Leaders across the $4 trillion healthcare industry will gather to explore how a new wave of innovation is revolutionizing the patient experience, making care more personal, accessible, and effective than ever before. This year's theme, “The Patient Care Revolution,” reflects a fundamental shift underway across the healthcare ecosystem. After decades of complexity, inefficiency, and barriers to access, a new model of care is emerging—one that puts patients at the center. At the Forbes Healthcare Summit, executives, entrepreneurs, and clinicians will share how they are redesigning healthcare delivery, leveraging technology to empower patients, and driving breakthroughs that improve outcomes and quality of life. “The pace of healthcare innovation has never been greater, but progress only happens when the right voices are in the same room
Show less
Read more
Impact Snapshot
Event Time:
VIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VIR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VIR alerts
High impacting Vir Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
VIR
News
- Vir Biotechnology (NASDAQ:VIR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Vir Biotechnology (NASDAQ:VIR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare ConferenceBusiness Wire
- Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile [YahoYaho
- Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety ProfileBusiness Wire
VIR
Earnings
- 11/5/25 - Miss
VIR
Analyst Actions
- 9/15/25 - HC Wainwright
VIR
Sec Filings
- 12/3/25 - Form 4
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- VIR's page on the SEC website